Cargando…

Emerging therapeutic options in inflammatory bowel disease

Inflammatory bowel disease (IBD) is a chronic disease that requires chronic treatment throughout the evolution of the disease, with a complex physiopathology that entails great challenges for the development of new and specific treatments for ulcerative colitis and Crohn´s disease. The anti-tumor ne...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamamoto-Furusho, Jesus K, Parra-Holguín, Norma N
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717021/ https://www.ncbi.nlm.nih.gov/pubmed/35068868 http://dx.doi.org/10.3748/wjg.v27.i48.8242

Ejemplares similares

Diagnostic Delay of Inflammatory Bowel Disease Is Significantly Higher in Public versus Private Health Care System in Mexican Patients
por: Yamamoto-Furusho, Jesús K., et al.
Publicado: (2021)

Pharmacogenetics in inflammatory bowel disease: understanding treatment response and personalizing therapeutic strategies
por: Yamamoto-Furusho, Jesús K
Publicado: (2017)

New treatment options in the management of IBD – focus on colony stimulating factors
por: Barahona-Garrido, Josué, et al.
Publicado: (2008)

Clinical differentiation of inflammatory bowel disease (IBD) in Latin America and the Caribbean
por: Yamamoto-Furusho, Jesús K., et al.
Publicado: (2022)

New treatment options for inflammatory bowel diseases
por: Verstockt, Bram, et al.
Publicado: (2018)

Mortality and Hospitalizations in Mexican Patients with Inflammatory Bowel Disease: Results from a Nationwide Health Registry
por: Sarmiento-Aguilar, Andrea, et al.
Publicado: (2020)

Indoleamine 2,3-Dioxygenase: Expressing Cells in Inflammatory Bowel Disease—A Cross-Sectional Study
por: Furuzawa-Carballeda, Janette, et al.
Publicado: (2013)

Antioxidants and mucosa protectives: realistic therapeutic options in inflammatory bowel disease?
por: Kruidenier, L, et al.
Publicado: (1998)

Growth Factors as Treatment for Inflammatory Bowel Disease: A Concise Review of the Evidence Toward Their Potential Clinical Utility
por: Barahona-Garrido, Josué, et al.
Publicado: (2009)

Aspects of inflammatory bowel disease during the COVID-19 pandemic and general considerations()
por: de León-Rendón, J.L., et al.
Publicado: (2020)

Regulation of the intestinal microbiota: An emerging therapeutic strategy for inflammatory bowel disease
por: Yue, Bei, et al.
Publicado: (2020)

Depression and Anxiety Disorders Impact in the Quality of Life of Patients with Inflammatory Bowel Disease
por: Yamamoto-Furusho, Jesús K., et al.
Publicado: (2021)

Differential Expression of IL-36 Family Members and IL-38 by Immune and Nonimmune Cells in Patients with Active Inflammatory Bowel Disease
por: Fonseca-Camarillo, Gabriela, et al.
Publicado: (2018)

2375. Association Between Clostridium difficile Colonization and Inflammatory Bowel Disease Activity
por: Morado-Aramburo, Oscar, et al.
Publicado: (2019)

Frailty in inflammatory bowel diseases: an emerging concept
por: Kochar, Bharati, et al.
Publicado: (2021)

Emerging Therapies for Inflammatory Bowel Disease
por: Weisshof, Roni, et al.
Publicado: (2018)

Emerging treatments for inflammatory bowel disease
por: Hazel, Karl, et al.
Publicado: (2020)

Phytotherapy: emerging therapeutic option in urologic disease
por: Kim, Sae Woong
Publicado: (2012)

Can control of gut microbiota be a future therapeutic option for inflammatory bowel disease?
por: Nishida, Atsushi, et al.
Publicado: (2021)

Policy Options for Infliximab Biosimilars in Inflammatory Bowel Disease Given Emerging Evidence for Switching
por: Husereau, Don, et al.
Publicado: (2018)

Inflammatory Markers in Dysmenorrhea and Therapeutic Options
por: Barcikowska, Zofia, et al.
Publicado: (2020)

Current and emerging drugs for the treatment of inflammatory bowel disease
por: Triantafillidis, John K, et al.
Publicado: (2011)

Catechins and Their Therapeutic Benefits to Inflammatory Bowel Disease
por: Fan, Fei-Yan, et al.
Publicado: (2017)

Therapeutic Oligonucleotides for Patients with Inflammatory Bowel Diseases
por: Marafini, Irene, et al.
Publicado: (2020)

Emerging Therapeutic Options for the Management of COPD
por: Reid, Debra J., et al.
Publicado: (2013)

Optimizing the Use of Current Treatments and Emerging Therapeutic Approaches to Achieve Therapeutic Success in Patients with Inflammatory Bowel Disease
por: Nakase, Hiroshi
Publicado: (2020)

Emerging therapeutic options for sporadic inclusion body myositis
por: Alfano, Lindsay N, et al.
Publicado: (2015)

Therapeutic drug monitoring in inflammatory bowel disease
por: Kopylov, Uri, et al.
Publicado: (2014)

Inflammasome Regulation: Therapeutic Potential for Inflammatory Bowel Disease
por: Xu, Qiuyun, et al.
Publicado: (2021)

Therapeutic Potential of Amino Acids in Inflammatory Bowel Disease
por: Liu, Yulan, et al.
Publicado: (2017)

The microbiota in inflammatory bowel disease: current and therapeutic insights
por: Lane, Erin R, et al.
Publicado: (2017)

Immunology of Inflammatory Bowel Disease: Molecular Mechanisms and Therapeutics
por: Lu, Quan, et al.
Publicado: (2022)

Emerging treatment options for short bowel syndrome: potential role of teduglutide
por: Tee, Cheng T, et al.
Publicado: (2011)

Inflammatory Bowel Disease Treatments and Predictive Biomarkers of Therapeutic Response
por: Elhag, Duaa Ahmed, et al.
Publicado: (2022)

Therapeutic Implications of Diet in Inflammatory Bowel Disease and Related Immune-Mediated Inflammatory Diseases
por: Jiang, Yan, et al.
Publicado: (2021)

Super Carbonate Apatite-miR-497a-5p Complex Is a Promising Therapeutic Option against Inflammatory Bowel Disease
por: Tsujimura, Naoto, et al.
Publicado: (2023)

Nutritional approach as therapeutic manipulation in inflammatory bowel disease
por: Yoon, Jin Young
Publicado: (2019)

Immunotherapy in inflammatory bowel disease: Novel and emerging treatments
por: Catalan-Serra, Ignacio, et al.
Publicado: (2018)

The emerging role of lncRNAs in inflammatory bowel disease
por: Yarani, Reza, et al.
Publicado: (2018)

Indications and surgical options for small bowel, large bowel and perianal Crohn's disease
por: Toh, James WT, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_0jq8sv0150mf7vac0h199eqosn